Page 22 - Vaccine

Moderna and Johnson & Johnson support Covid-19 vaccine boosters

The FDA panel will meet on Thursday and Friday to weigh the evidence for booster doses

Bharat Biotech's Covaxin gets expert panel's nod for children above 2 years

First Covid-19 vaccine in the world for children this young

Expert panel allows adolescent trials of J&J vaccine with riders

SEC asks J&J to monitor adverse events closely for next three months

Vaccine diplomacy and drama

India transferred five million jabs to Britain in need

75 countries add to calls for global solidarity for vaccine equity

The pandemic knows no borders, the only solution lies in global solidarity, unity and multilateral cooperation, said the countries in a joint statement.

Kerala Health Minister launches pneumococcal conjugate vaccine for infants

Kerala Health Minister Veena George launched the pneumococcal conjugate vaccine for infants as part of the state's Universal Immunisation Programme at the Government Women And Children's Hospital

MSD launches gender-neutral HPV vaccine in India, licences Covid jab

HPV infections are one of the leading causes of cervical cancer in women

New AstraZeneca tie-up to explore vaccine tech for cancer, heart disease

An Imperial College London start-up has tied up with British-Swedish biopharmaceutical major AstraZeneca to explore the therapeutic uses of its vaccine technology

Sanofi drops plans for messenger RNA vaccine against coronavirus

French drugmaker Sanofi said Tuesday it was shelving plans for a Covid-19 vaccine based on messenger RNA despite positive results from early stage testing

Home Covid-19 vaccinations for those with restricted mobility: Govt

The health ministry has also cautioned that "open vial policy" is not acceptable for Covid vaccines

66% adults in India have got first Covid-19 vaccine dose: Health ministry

Only 6% of vaccinations done in private hospitals since May: Health ministry

Covid-19 vaccine: AstraZeneca to develop Imperial's new RNA technology

Under the deal, VaxEquity, a start-up founded by Imperial vaccinologist Robin Shattock, could receive up to $195 million if certain milestones are met

EU regulator to decide on Pfizer booster dose at the start of October

Pfizer declined to comment, while BioNTech was not available for comment

India's coronavirus vaccination figure crosses 84 crore doses

The cumulative number of COVID-19 vaccine doses administered in the country crossed 84 crore on Thursday, the Union Health Ministry said. As many as 65,26,432 doses were administered on Thursday till 7 pm, it said The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late night. The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level, the ministry underlined. The countrywide vaccination drive was rolled out on January 16 with healthcare workers (HCWs) getting inoculated in the first phase. The vaccination of frontline workers (FLWs) started from February 2. The next phase of vaccination commenced from March 1 for people over 60 years of age and those aged 45 and above with specified co-morbid conditions. The country launched vaccination for all people aged more than 45 years from April 1. The governm

Bharat Biotech injects pace into Covid-19 vaccine Covaxin supply

Constraints on the availability of India's first indigenous Covid-19 vaccine could end soon

Johnson & Johnson says Covid-19 booster shot is 94% effective

J&J said a booster given two months after the first dose increased antibody levels four to six-fold

India warns of 'reciprocal measures' if UK doesn't recognise Covishield

India on its part does not insist on vaccination and has done away with institutional quarantine for foreigners entering the country

Pfizer Covid-19 vaccine safely bolsters antibodies in younger kids

Drugmaker, partner BioNTech to submit data to US regulators

Covid-19 vax export curbs may ease in two months: Adar Poonawalla

Poonawalla said easing the export restrictions is a government of India's decision, and he will go by what the Centre feels is appropriate

Covid-19 jabs cross 22-million mark on PM Narendra Modi's birthday

Business Standard's analysis showed that of the 20 million doses on Friday, nearly 40 per cent were second and remaining 60 per cent were first doses